BIM
CORT icon

BlackRock Investment Management’s Corcept Therapeutics CORT Stock Holding History

BlackRock Investment Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.08M Sell
286,334
-914
-0.3% -$7.16K ﹤0.01% 2194
2016
Q3 		$1.87M Sell
287,248
-549
-0.2% -$3.19K ﹤0.01% 2212
2016
Q2 		$1.57M Buy
287,797
+65,896
+30% +$343K ﹤0.01% 2309
2016
Q1 		$1.04M Buy
221,901
+4,532
+2% +$17.7K ﹤0.01% 2460
2015
Q4 		$1.08M Buy
217,369
+1,992
+0.9% +$8.98K ﹤0.01% 2547
2015
Q3 		$810K Sell
215,377
-4,789
-2% -$24.3K ﹤0.01% 2753
2015
Q2 		$1.32M Buy
220,166
+62,564
+40% +$384K ﹤0.01% 2566
2015
Q1 		$883K Buy
157,602
+2,384
+2% +$8.63K ﹤0.01% 2606
2014
Q4 		$466K Sell
155,218
-736
-0.5% -$2.24K ﹤0.01% 3049
2014
Q3 		$418K Sell
155,954
-2,059
-1% -$5.45K ﹤0.01% 3063
2014
Q2 		$442K Buy
158,013
+10,049
+7% +$29.7K ﹤0.01% 3098
2014
Q1 		$645K Buy
147,964
+1,947
+1% +$6.8K ﹤0.01% 2812
2013
Q4 		$469K Sell
146,017
-2,169
-1% -$4.38K ﹤0.01% 2978
2013
Q3 		$236K Buy
148,186
+12,286
+9% +$21.7K ﹤0.01% 3158
2013
Q2 		$235K Buy
+135,900
New +$244K ﹤0.01% 3134

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Investment Management's CORT Position: Q4 2016 in Review

BlackRock Investment Management reduced its Corcept Therapeutics (CORT) stake by 0.32% in Q4 2016, selling an estimated $7.16K and leaving 286,334 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

BlackRock Investment Management first reported a position in CORT in Q2 2013 and has held it in 15 quarters since. 135 funds tracked by Wall St. Rank hold CORT as of Q4 2016.

  • BlackRock Investment Management held 286,334 shares of Corcept Therapeutics worth $2.08M as of Q4 2016.
  • BlackRock Investment Management sold 914 Corcept Therapeutics shares in Q4 2016, an estimated $7.16K.
  • Corcept Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2194 holding.
  • BlackRock Investment Management first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • 135 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.